Baidu
map

叕上央视,三明模式推全国:药代被抓、第三方查医生、药企写保证.......

2017-01-01 田边 赛柏蓝

听说了吗,有关部门已经下达了抓药代的“指标”! 据了解,天津某药企的代表,在云大一附院被抓了!烟台某医院抓了2个。有代表在山东省立医院被搜包;3名代表被医院保安“擒获”,并拍照“留念”(如图)。 ▍药代被抓,药企放假 图片在网络疯传,传递的是药代人人自危的恐慌,大家需要一个载体来提醒同伴危险迫近,潜意识里也有抱团度过危机的期待,而这一类的图片是最恰当不过素材。也有消息

听说了吗,有关部门已经下达了抓药代的“指标”!

 

据了解,天津某药企的代表,在云大一附院被抓了!烟台某医院抓了2个。有代表在山东省立医院被搜包;3名代表被医院保安“擒获”,并拍照“留念”(如图)。

 


药代被抓,药企放假

 

图片在网络疯传,传递的是药代人人自危的恐慌,大家需要一个载体来提醒同伴危险迫近,潜意识里也有抱团度过危机的期待,而这一类的图片是最恰当不过素材。也有消息说,图片里的几位是卖鞋油的,那就更让人倍感凄凉:药代和卖鞋油的,在医院的“待遇”已经变得一样了。

 

部分国内企业已经放假几天了;也有企业集中讨论了应对的技巧,要求代表在院内的动作务必谨慎,年终答谢取消的可能性很大。根据微友的反馈,也有部分企业选择内训,来过渡行业危机,外企和国内企业都有。

 

是不是觉得已经透不过起来?还没完,一项重大政治改革的推行,预示着医疗反腐将会更加严密、深入。

 

国家监察体制改革试点,医疗反腐只是刚开始

 

与央视曝光几乎同时, 党中央决定12月26日起,在北京、山西、浙江开展国家监察体制改革试点,成立监察委员会,加大反腐力度。这是个重大的政治改革,简单说,纪委管党内违纪,而监察委员会监管对象是所有行使公权力的人员,包括事业单位。

 

众所周知,针对党政机关的反腐已经进行了很长的时间,下一步将有可能面向事业单位推进,医疗行业则是关系到百姓切身利益的领域,反腐加力必不可少。

 

从现实条件看,现在医疗反腐已经具备了一定的条件,国家在医改上已经找到了新的突破,反腐、严查商业贿赂不至于影响到百姓的基本医疗保障。

 

央视曝光只是连环炮的第一枪。凭借央视这一枪,把阻碍医改进行的顽疾弊病彰显无遗,步入深水区的医改,勇猛向腐败宣战,砍掉病枝长新芽。所要推行的改革方案,被央视高频密集播出后,给出了明确的信号。

 

三明再上央视,除了“两票制”,影响行业的还有很多

 

继12月24日,《焦点访谈》 曝光药代行贿的节目末端,着力介绍了三明医改后。12月29日,和三明医改的掌舵人——詹积富预告的一样:央视一套晚上10点的《晚间新闻——深读深改》里,又一次将三明模式做浓墨重彩的描绘。


 

在节目里,主持人讲到:“三明医改的突破口选择了最难啃的硬骨头——医药流通领域。过去一种药卖出去,药企卖个出厂价,赚得很少;医药代表把药挤进医院要加价。”对三明“两票制”和“腾虹换鸟”方案的赞许。

 

这样明确的信号释放下,三明模式推广全国再也没有悬念。压缩药价、两票制、雇第三方抓医生受贿、药企写保证书不带金……这些带着三明烙印的医改新政,即将影响行业的每个人。

 

 “如果全国300万的医药代表大军不消失,不转行;老百姓不可能不吃冤枉药,不开冤枉刀,不花冤枉钱”。这句话裹挟着冷风、一道寒光扑面而来,药代药企感受到冰凉了吗?

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1666638, encodeId=ff7d16666380c, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Wed Aug 02 19:40:00 CST 2017, time=2017-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949571, encodeId=026819495e123, content=<a href='/topic/show?id=c466e57725a' target=_blank style='color:#2F92EE;'>#第三方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75772, encryptionId=c466e57725a, topicName=第三方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon Nov 27 23:40:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167299, encodeId=8a4216e29906, content=拭目以待, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Sun Jan 01 20:57:34 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167290, encodeId=83c816e290b4, content=傻子的幸福生活, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cdf1948157, createdName=Peter程, createdTime=Sun Jan 01 19:19:06 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167268, encodeId=d12416e26841, content=三明是彻底的失败, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9bc45f4ae162bd654210831f4e7ea3d0.jpg, createdBy=bbf11609910, createdName=杨帆7792, createdTime=Sun Jan 01 16:04:05 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167237, encodeId=fb2816e23705, content=大家好,这个应用很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161124/IMG5836DA0DD6D5B8175.jpg, createdBy=33c196714, createdName=bxj405, createdTime=Sun Jan 01 13:01:40 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
    2017-08-02 fengyqf
  2. [GetPortalCommentsPageByObjectIdResponse(id=1666638, encodeId=ff7d16666380c, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Wed Aug 02 19:40:00 CST 2017, time=2017-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949571, encodeId=026819495e123, content=<a href='/topic/show?id=c466e57725a' target=_blank style='color:#2F92EE;'>#第三方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75772, encryptionId=c466e57725a, topicName=第三方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon Nov 27 23:40:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167299, encodeId=8a4216e29906, content=拭目以待, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Sun Jan 01 20:57:34 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167290, encodeId=83c816e290b4, content=傻子的幸福生活, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cdf1948157, createdName=Peter程, createdTime=Sun Jan 01 19:19:06 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167268, encodeId=d12416e26841, content=三明是彻底的失败, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9bc45f4ae162bd654210831f4e7ea3d0.jpg, createdBy=bbf11609910, createdName=杨帆7792, createdTime=Sun Jan 01 16:04:05 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167237, encodeId=fb2816e23705, content=大家好,这个应用很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161124/IMG5836DA0DD6D5B8175.jpg, createdBy=33c196714, createdName=bxj405, createdTime=Sun Jan 01 13:01:40 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1666638, encodeId=ff7d16666380c, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Wed Aug 02 19:40:00 CST 2017, time=2017-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949571, encodeId=026819495e123, content=<a href='/topic/show?id=c466e57725a' target=_blank style='color:#2F92EE;'>#第三方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75772, encryptionId=c466e57725a, topicName=第三方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon Nov 27 23:40:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167299, encodeId=8a4216e29906, content=拭目以待, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Sun Jan 01 20:57:34 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167290, encodeId=83c816e290b4, content=傻子的幸福生活, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cdf1948157, createdName=Peter程, createdTime=Sun Jan 01 19:19:06 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167268, encodeId=d12416e26841, content=三明是彻底的失败, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9bc45f4ae162bd654210831f4e7ea3d0.jpg, createdBy=bbf11609910, createdName=杨帆7792, createdTime=Sun Jan 01 16:04:05 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167237, encodeId=fb2816e23705, content=大家好,这个应用很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161124/IMG5836DA0DD6D5B8175.jpg, createdBy=33c196714, createdName=bxj405, createdTime=Sun Jan 01 13:01:40 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
    2017-01-01 jiangxianchen

    拭目以待

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1666638, encodeId=ff7d16666380c, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Wed Aug 02 19:40:00 CST 2017, time=2017-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949571, encodeId=026819495e123, content=<a href='/topic/show?id=c466e57725a' target=_blank style='color:#2F92EE;'>#第三方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75772, encryptionId=c466e57725a, topicName=第三方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon Nov 27 23:40:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167299, encodeId=8a4216e29906, content=拭目以待, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Sun Jan 01 20:57:34 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167290, encodeId=83c816e290b4, content=傻子的幸福生活, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cdf1948157, createdName=Peter程, createdTime=Sun Jan 01 19:19:06 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167268, encodeId=d12416e26841, content=三明是彻底的失败, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9bc45f4ae162bd654210831f4e7ea3d0.jpg, createdBy=bbf11609910, createdName=杨帆7792, createdTime=Sun Jan 01 16:04:05 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167237, encodeId=fb2816e23705, content=大家好,这个应用很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161124/IMG5836DA0DD6D5B8175.jpg, createdBy=33c196714, createdName=bxj405, createdTime=Sun Jan 01 13:01:40 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
    2017-01-01 Peter程

    傻子的幸福生活

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1666638, encodeId=ff7d16666380c, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Wed Aug 02 19:40:00 CST 2017, time=2017-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949571, encodeId=026819495e123, content=<a href='/topic/show?id=c466e57725a' target=_blank style='color:#2F92EE;'>#第三方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75772, encryptionId=c466e57725a, topicName=第三方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon Nov 27 23:40:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167299, encodeId=8a4216e29906, content=拭目以待, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Sun Jan 01 20:57:34 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167290, encodeId=83c816e290b4, content=傻子的幸福生活, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cdf1948157, createdName=Peter程, createdTime=Sun Jan 01 19:19:06 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167268, encodeId=d12416e26841, content=三明是彻底的失败, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9bc45f4ae162bd654210831f4e7ea3d0.jpg, createdBy=bbf11609910, createdName=杨帆7792, createdTime=Sun Jan 01 16:04:05 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167237, encodeId=fb2816e23705, content=大家好,这个应用很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161124/IMG5836DA0DD6D5B8175.jpg, createdBy=33c196714, createdName=bxj405, createdTime=Sun Jan 01 13:01:40 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
    2017-01-01 杨帆7792

    三明是彻底的失败

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1666638, encodeId=ff7d16666380c, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Wed Aug 02 19:40:00 CST 2017, time=2017-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949571, encodeId=026819495e123, content=<a href='/topic/show?id=c466e57725a' target=_blank style='color:#2F92EE;'>#第三方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75772, encryptionId=c466e57725a, topicName=第三方)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon Nov 27 23:40:00 CST 2017, time=2017-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167299, encodeId=8a4216e29906, content=拭目以待, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Sun Jan 01 20:57:34 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167290, encodeId=83c816e290b4, content=傻子的幸福生活, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cdf1948157, createdName=Peter程, createdTime=Sun Jan 01 19:19:06 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167268, encodeId=d12416e26841, content=三明是彻底的失败, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9bc45f4ae162bd654210831f4e7ea3d0.jpg, createdBy=bbf11609910, createdName=杨帆7792, createdTime=Sun Jan 01 16:04:05 CST 2017, time=2017-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167237, encodeId=fb2816e23705, content=大家好,这个应用很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161124/IMG5836DA0DD6D5B8175.jpg, createdBy=33c196714, createdName=bxj405, createdTime=Sun Jan 01 13:01:40 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
    2017-01-01 bxj405

    大家好,这个应用很好

    0

Baidu
map
Baidu
map
Baidu
map